AI-powered treatment response prediction from 2-min rs-fMRI, optimizing neuropsychiatric trials and saving up to $116M per approved drug.
QuantaBrain has raised $462K in total funding. The most recent round was Grant. The last funding was announced in June 2025.
QuantaBrain's investors include Scientifica Venture Capital, Rigel Ventures.
QuantaBrain is headquartered in Pisa, Italy.
AI-powered treatment response prediction from 2-min rs-fMRI, optimizing neuropsychiatric trials and saving up to $116M per approved drug.
QuantaBrain is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"QuantaBrain — Funding & Investors." VCBacked, June 15, 2025, https://www.vcbacked.co/company/quantabrain. Accessed November 15, 2026.
VCBacked. (2025). QuantaBrain — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/quantabrain
{{cite web |title=QuantaBrain — Funding & Investors |url=https://www.vcbacked.co/company/quantabrain |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at QuantaBrain? Request a listing update